Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/use-of-axillary-staging-in-the-management-of-ductal-carcinoma-in-situ-7wSuggc1BO
References (7)
-
G. Zavagno, G. Salvo, G. Scalco, F. Bozza, L. Barutta, P. Bianco, M. Renier, C. Racano, P. Carraro, D. Nitti (2008)
A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM TrialAnnals of Surgery, 247
-
U. Veronesi, G. Paganelli, G. Viale, A. Luini, S. Zurrida, V. Galimberti, M. Intra, P. Veronesi, C. Robertson, P. Maisonneuve, G. Renne, C. Cicco, F. Lucia, R. Gennari (2003)
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.The New England journal of medicine, 349 6
-
D. Krag, S. Anderson, T. Julian, A. Brown, S. Harlow, J. Costantino, T. Ashikaga, D. Weaver, E. Mamounas, L. Jalovec, T. Frazier, D. Noyes, A. Robidoux, H. Scarth, N. Wolmark (2010)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.The Lancet. Oncology, 11 10
-
EJ Coromilas, JD Wright, Y Huang
The influence of hospital and surgeon factors on the prevalence of axillary evaluation in ductal carcinoma in situ [published online April 9, 2015]. -
D. Krag, D. Weaver, J. Alex, J. Fairbank (1993)
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surgical oncology, 2 6
-
M. Brennan, R. Turner, S. Ciatto, M. Marinovich, J. French, P. Macaskill, N. Houssami (2011)
Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.Radiology, 260 1
-
E. Coromilas, J. Wright, Yongmei Huang, S. Feldman, A. Neugut, Ling Chen, D. Hershman (2015)
The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.JAMA oncology, 1 3
- Publisher
- American Medical Association
- Copyright
- Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
- ISSN
- 2374-2437
- eISSN
- 2374-2445
- DOI
- 10.1001/jamaoncol.2015.0390
- pmid
- 26181181
- Publisher site
- See Article on Publisher Site
Abstract
Research Original Investigation Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ 45. Pernas S, Gil M, Benítez A, et al. Avoiding axillary treatment in the management of patients 51. Osako T, Iwase T, Ushijima M, et al. Incidence axillary treatment in sentinel lymph node with early breast cancer. Breast Cancer Res Treat. and prediction of invasive disease and nodal micrometastases of breast cancer: a prospective 2006;95(3):279-293. metastasis in preoperatively diagnosed ductal analysis of axillary or distant recurrence. Ann Surg carcinoma in situ. Cancer Sci. 2014;105(5):576-582. 48. Veronesi U, Paganelli G, Viale G, et al. Oncol. 2010;17(3):772-777. A randomized comparison of sentinel-node biopsy 52. Khuri SF, Daley J, Henderson W, et al. Relation 46. Lucci A, McCall LM, Beitsch PD, et al; American with routine axillary dissection in breast cancer. of surgical volume to outcome in eight common College of Surgeons Oncology Group. Surgical N Engl J Med. 2003;349(6):546-553. operations: results from the VA National Surgical complications associated with sentinel lymph node Quality Improvement Program. Ann Surg. 1999;230 49. McMasters KM, Chao C, Wong SL, Martin RC III, dissection (SLND) plus axillary lymph node (3):414-429. Edwards MJ. Sentinel lymph node biopsy in dissection compared with SLND alone in the
Journal
JAMA Oncology – American Medical Association
Published: Jun 1, 2015